NEW YORK–(BUSINESS WIRE)–Ophthotech announced completion of recruitment for its Phase 2b clinical trial of Zimura® for patients with geographic atrophy secondary to dry AMD.
Month: October 2018
Dual-eligible Medicare, Medicaid beneficiaries subject to persistently high costs
More than half of high-cost patients who were dually eligible for Medicare and Medicaid continued to have high costs over 3 years, according to research published in Annals of Internal Medicine.“Little is known about the persistence of high-cost status…
VIDEO: EDOF IOL using pinhole effect lessens ocular effects
VIENNA — Gerd Auffarth, MD, discusses at the European Society of Cataract and Refractive Surgeons meeting how the IC-8 IOL from AcuFocus has fewer visual side effects than other extended depth of focus lenses because of the pinhole technology in the le…
North American Rescue Audio Bleeding Control Kit: Product Review
Trauma is a leading cause of death and disability worldwide. To this day, it remains the number one cause of death for individuals under the age of 47. Studies show that blood loss, or the consequences thereof, accounts for nearly 40% of these trauma deaths and about half occur at the scene of the injury […]
Kala announces common stock public offering
Kala Pharmaceuticals announced a public offering of 7.5 million shares of its common stock at $8.25 per share, according to a press release.Underwriters of the offering will have the option to purchase an additional 1.125 million shares at the public o…
Vagus Nerve Stimulator Doubles Movement Recovery in Stroke Patients
Researchers at the University of Texas at Dallas have developed and helped to commercialize a vagus nerve stimulator therapy, which significantly enhanced movement recovery in stroke patients undergoing rehab in a recent study. The device, called the Vivistim, is currently being tested and developed by a UT Dallas spinoff company called MicroTransponder. The implant is […]
Nanoparticles Encapsulating Chemotherapy Drugs to Kill Triple Negative Breast Cancer
The cells of triple negative breast cancer tumors don’t have receptors for estrogen, progesterone, and HER2, the main targets used to attack breast cancers. This is why they’re so difficult to treat, but researchers at George Washington University have shown that a technique of delivering a chemotherapy agent within specially designed nanoparticles can be very powerful […]
Samenvatting: Eyenuk, Inc. Breidt uit naar Duitsland met de lancering van EyeArt® Artificial Intelligence Eye Screening voor diabetische retinopathie
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc. kondigt zijn uitbreiding naar Duitsland aan met de toepassing van EyeArt® artificial intelligence (AI)-technologie voor de screening van diabetische retinopathie in het Diabetescentrum Mergentheim in Bad Merge…
Resumen: Eyenuk, Inc. se expande en Alemania con el lanzamiento de EyeArt®, la tecnología de examen ocular con inteligencia artificial para la retinopatía diabética
LOS ÁNGELES–(BUSINESS WIRE)–Eyenuk, Inc. ha anunciado su expansión en Alemania con la adopción de la tecnología de inteligencia artificial EyeArt® para la detección de la retinopatía diabética en el Centro de diabetes Mergentheim en Bad Mergentheim (…
Eyenuk, Inc. expandiert nach Deutschland mit Markteinführung von EyeArt® Augenuntersuchungen auf diabetische Retinopathie mit Künstlicher Intelligenz
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc. gibt seine Expansion nach Deutschland mit der Übernahme der Technologie EyeArt® für Untersuchungen auf diabetische Retinopathie mit Künstlicher Intelligenz (KI) im Diabetes Zentrum Mergentheim in Bad Mergenthe…
Eyevance acquires worldwide rights to corneal epithelial defect candidate Nexagon
Eyevance Pharmaceuticals has acquired worldwide licensing rights to Nexagon, a 30-base antisense oligomer treatment candidate for persistent corneal epithelial defect, according to a press release.A worldwide licensing agreement with OcuNexus Therapeut…
Obalon Touch Automated Inflator for Intragastric Balloons
Obalon Therapeutics, a company that makes swallowable, gas-filled intragastric balloons that are an option over bariatric surgeries, won FDA approval for the Obalon Touch automated inflation system. The new product is used to inflate the Obalon Balloon and is going to be made available along with the new Obalon Navigation System (pending FDA approval), an […]
Augmented Reality Meets Industrial Use in IngenioSpec’s Eyewear Patent Portfolio
SAN JOSE, Calif.–(BUSINESS WIRE)–IngenioSpec announces the addition of US patents 10,060,790 and 10,061,144 to its robust eyewear portfolio. The portfolio covers basic structures for electronic eyewear as well as features such as customizing differen…
3-D system offers advantages for learning surgery
Athanasios NikolakopoulosVIENNA — There is no reason to be afraid of using a heads-up 3-D viewing modality to perform surgery because the advantages are immediately appreciated when surgeons try it, according to one specialist.“The 4K Ngenuity system (…
Eye Health America Acquires Local South Carolina Optometry Practice of Dr. Sara Bopp, O.D.
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), a leader in eye care practice management, has announced the acquisition of a local Simpsonville, South Carolina, optometry practice, its fifth acquisition since the company was established less than a…
Eyenuk, Inc. s’implante en Allemagne avec le lancement du dépistage des troubles de la vue par intelligence artificielle EyeArt® pour la rétinopathie diabétique
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc. annonce son expansion en Allemagne avec l’adoption de la technologie d’intelligence artificielle (IA) EyeArt® pour le dépistage de la rétinopathie diabétique au Centre pour le diabète Mergentheim de Bad Mergen…
VIDEO: OCT technology reveals unknown features of area behind posterior capsule
VIENNA — Using OCT integrated into the Lumera microscope (Zeiss), Marie-José Tassignon, MD, PhD, was able to explore the anatomy of the space behind the posterior capsule. At the European Society of Cataract and Refractive Surgeons meeting, she speaks …
Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, announce…
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that Keith Westby, COO, will present an overview of the Company at Chardan’s 2nd Annual Genetic Medicines Conference.
Riassunto: Eyenuk, Inc. si espande in Germania con il lancio di EyeArt®, una tecnologia per l’esame del fondo oculare basato sull’intelligenza artificiale per la rilevazione della retinopatia diabetica
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc. annuncia la propria espansione in Germania con l’adozione della tecnologia per la rilevazione della retinopatia diabetica basata sull’intelligenza artificiale EyeArt® presso il Centro per il diabete di Mergent…